FIELD: biotechnology; virology; medicine.
SUBSTANCE: vaccine for promoting the prevention of a disease due to FCV, containing the specified immunogenic composition, and a method for immunizing a feline animal against pathogenic FCV are proposed. An immunogenic composition containing an RNA replicon particle of Venezuelan equine encephalitis (VEE) alphavirus, which encodes the capsid protein of feline calcivirus (FCV) and a modified live feline pathogen selected from the group consisting of a modified live feline viral rhinotracheitis virus (FVR), modified live feline panleukopenia virus (FPLV), modified live Chlamydophila felis, and any combination thereof are proposed.
EFFECT: invention makes it possible to obtain polyvalent vaccines for felines.
14 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE AGAINST FELINE CALICIVIRUS | 2018 |
|
RU2792898C2 |
| VACCINE AGAINST FELINE LEUKEMIA VIRUS | 2018 |
|
RU2784533C2 |
| VACCINE AGAINST RABIES VIRUS | 2018 |
|
RU2782350C2 |
| ALPHAVIRUS REPLICON PARTICLE | 2018 |
|
RU2795596C2 |
| VACCINE TO SWINE INFLUENZA A VIRUS | 2018 |
|
RU2787596C2 |
| FMDV RECOMBINANT VACCINES AND USE THEREOF | 2015 |
|
RU2745373C2 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| VACCINE COMPOSITION FOR TREATMENT OF CANCER | 2018 |
|
RU2782261C2 |
| PORCINE PARVOVIRUS | 2015 |
|
RU2817872C2 |
| AFRICAN SWINE FEVER VACCINE | 2020 |
|
RU2819672C2 |
